Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
mRNA-1273 Emergency use authorization Experimental Vaccine Apr/02/2021 18 0
BNT162b2 Emergency use authorization Experimental Vaccine Apr/02/2021 33 0
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/01/2021 11 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/31/2021 40 44
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2021 17 2
BBV152 Emergency use authorization Experimental Vaccine Mar/27/2021 7 0
Ribavirin Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021 10 2
Remdesivir Approved by FDA Experimental Antiviral Mar/23/2021 60 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
GS‐441524 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/19/2021 2 0